173273-87-5

Upstream product

• 98-88-4 benzoyl chloride 
• 173273-86-4 methyl 2,6-di-O-benzoyl-3-O-levulinoyl-1-thio-β-D-galactopyranoside 
• 40608-06-8 levulinic anhydride 
• 97205-28-2 methyl 2,3-di-O-benzoyl-1-thio-β-D-galactopyranoside 

Downstream Products

• 418763-66-3 (2,4,6-tri-O-benzoyl-3-O-levulinoyl-β-D-galactopyranosyl)-(1->3)-2-O-acetyl-4,6-O-benzylidene-N-benzyloxycarbonyl-1,5-dideoxy-1,5-imino-D-glucitol 
• 173273-90-0 (2,4,6-tri-O-benzoyl-3-O-levulinoyl-β-D-galactopyranosyl)-(1->3)-2-O-acetyl-N-benzyloxycarbonyl-6-O-tert-butyldimethylsilyl-1,5-dideoxy-1,5-imino-D-glucitol 
• 173273-89-7 (2,4,6-tri-O-benzoyl-3-O-levulinoyl-β-D-galactopyranosyl)-(1->3)-2-O-acetyl-N-benzyloxycarbonyl-1,5-dideoxy-1,5-imino-D-glucitol 

Relevant academic research and scientific papers

Synthesis of sialyl- and sulfo-Lex/Lea analogs containing N-alkyl-1-deoxynojirimycin as potential selectin blockers

A series of novel sialyl- and sulfo-Lex/Lea oligosaccharides containing N-alkyl-1-deoxynojirimycin as potential selectin blockers have systematically been synthesized via the suitably protected intermediates containing N-benzyloxycar